Medicare is negotiating to lower the price of several major drugs aimed at treating chronic conditions, cancers, and autoimmune treatments.

The U.S. government plans to lower Medicare costs for Botox by targeting its medical uses, marking a major shift in drug ...

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

The list has been announced by the Centers for Medicare & Medicaid Services (CMS) shortly after the reductions agreed for the ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

List includes medications for diabetes, cancer, arthritis, and more ...

Before you schedule an injection, read this.